A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2M
Phase 1
- Conditions
- Prostate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancer
- Registration Number
- JPRN-UMIN000015356
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
(1) In a clinical trial, patients who need to receive the new treatment (2) Patinets with severe pulmonary, renal, gastrointestinal, hematological or psychonurological disease (3) Patients whose doctors determined as inadequate for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety: Subjective and Objective symptom, Vital data, Clinical tests, Radiation exposure, Adverse events
- Secondary Outcome Measures
Name Time Method 1) Pharmacokinetics 2) Detection of cancer focus 3) PET imaging condition 4) Imaging of tumor neovascular